GLOW: three compounds, one vial, and what that means

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
GLOW is a single lyophilized vial containing GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg — 70 mg in total. Because the three are combined before lyophilisation, they cannot be separated at the bench, and no observation made with the blend can be attributed to any one of them.

The three components

GHK-Cu is the copper-binding tripeptide glycyl-histidyl-lysine, isolated from human plasma by Loren Pickart and characterised over several decades of work on matrix and dermal models. TB-500 is a synthetic fragment related to thymosin beta-4, the actin-binding protein described by Allan Goldstein and colleagues. BPC-157 is a pentadecapeptide derived from a sequence in gastric juice, studied principally by the Sikiric group in Zagreb.

Each has its own literature, its own models and its own open questions. They are not variants of one another and they were not studied together.

Why they are sold in one vial

A single vial is one carton, one batch record and one reconstitution. For a laboratory running a combined-exposure model, that is simpler than three vials and three records, and it removes the risk of the three coming from different lots.

The convenience is real. It is also the whole of the argument — combining them is a packaging decision, not a finding about the compounds.

The limit, stated plainly

Once three compounds are lyophilized together they cannot be separated at the bench. Any result obtained with GLOW is a result about the mixture at that composition, and attributing it to the copper peptide, or the thymosin fragment, or BPC-157 is a claim the material cannot support.

A design that needs attribution needs separate vials and an arm per compound. REVIVE LAB UAE sells all three separately where the catalogue has them, and a study that must name a cause should use those instead.

What the blend is good for

Screening a combined exposure, reproducing a formulation-level observation, or asking whether a mixture does something none of the single compounds did at the same concentrations — provided single-compound arms are run alongside.

Supplied for laboratory research use only, with batch identity by mass spectrometry and purity by HPLC. REVIVE LAB UAE provides no dosing, administration or protocol guidance of any kind.

What it costs

FormatStrengthPriceAvailability
GLOW Pack70 mg blendAED 1050In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

The three components?

GHK-Cu is the copper-binding tripeptide glycyl-histidyl-lysine, isolated from human plasma by Loren Pickart and characterised over several decades of work on matrix and dermal models. TB-500 is a synthetic fragment related to thymosin beta-4, the actin-binding protein described by Allan Goldstein and colleagues. BPC-157 is a pentadecapeptide derived from a sequence in gastric juice, studied principally by the Sikiric group in Zagreb.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

GLOW Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.